150 related articles for article (PubMed ID: 17639509)
1. A preliminary study of the baboon prostate pathophysiology.
Mubiru JN; Hubbard GB; Dick EJ; Butler SD; Valente AJ; Troyer DA; Rogers J
Prostate; 2007 Sep; 67(13):1421-31. PubMed ID: 17639509
[TBL] [Abstract][Full Text] [Related]
2. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
[TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
[TBL] [Abstract][Full Text] [Related]
4. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
[TBL] [Abstract][Full Text] [Related]
5. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
[TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
7. A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer.
Mubiru JN; Valente AJ; Troyer DA
Prostate; 2005 Oct; 65(2):117-23. PubMed ID: 15880524
[TBL] [Abstract][Full Text] [Related]
8. Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer.
Mubiru JN; Shen-Ong GL; Valente AJ; Troyer DA
Gene; 2004 Feb; 327(1):89-98. PubMed ID: 14960364
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
10. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
Kaić G; Tomasović-Loncarić C
Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
12. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score.
Murphy AJ; Hughes CA; Lannigan G; Sheils O; O'Leary J; Loftus B
Histopathology; 2007 Jan; 50(2):243-51. PubMed ID: 17222253
[TBL] [Abstract][Full Text] [Related]
14. Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases.
Mubiru JN; Hubbard GB; Dick EJ; Furman J; Troyer DA; Rogers J
Prostate; 2008 Oct; 68(14):1546-54. PubMed ID: 18668524
[TBL] [Abstract][Full Text] [Related]
15. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology.
Shen-Ong GL; Feng Y; Troyer DA
Cancer Res; 2003 Jun; 63(12):3296-301. PubMed ID: 12810662
[TBL] [Abstract][Full Text] [Related]
17. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
[TBL] [Abstract][Full Text] [Related]
18. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression.
Takahara K; Azuma H; Sakamoto T; Kiyama S; Inamoto T; Ibuki N; Nishida T; Nomi H; Ubai T; Segawa N; Katsuoka Y
Anticancer Res; 2009 Jul; 29(7):2497-505. PubMed ID: 19596919
[TBL] [Abstract][Full Text] [Related]
19. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
Levin AM; Zuhlke KA; Ray AM; Cooney KA; Douglas JA
Prostate; 2007 Oct; 67(14):1507-13. PubMed ID: 17683075
[TBL] [Abstract][Full Text] [Related]
20. Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.
Zehentner BK; Secrist H; Zhang X; Hayes DC; Ostenson R; Goodman G; Xu J; Kiviat M; Kiviat N; Persing DH; Houghton RL
Mol Diagn Ther; 2006; 10(6):397-403. PubMed ID: 17154657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]